Grapiprant | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Grapiprant
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Grapiprant

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 4 NDC API, 2 VMF, 5 Listed Suppliers, $ API Reference Price

10 API Suppliers
4 NDC API
2 VMF
5 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

FINISHED DOSAGE FORMULATIONS

6 FDF Dossiers, 3 Canada, 3 Listed Dossiers

6 FDF Dossiers
3 Canada
3 Listed Dossiers

DIGITAL CONTENT

2 News #PharmaBuzz

2 News #PharmaBuzz

MARKET PLACE

2 APIs

2 APIs

PATENTS & EXCLUSIVITIES

6 Health Canada Patents

6 Health Canada Patents

$ API Ref.Price (USD/KG) : 3,790 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 6Gowling WLG (Canada) LLP

filter Patent Reset all filters

6 All

01 32426457

02 32600510

filter Product Reset all filters

6 All

01 6GRAPIPRANT

filter Dosage Reset all filters

6 All

01 6TABLET

filter Exp Date Reset all filters

6 All

01 32021-10-15

02 32026-03-01

Product Main Page

01

Gowling WLG (Canada) LLP

Grapiprant

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-03-01

Date Granted : 2010-11-02

Brand Name : GALLIPRANT

Patent Number : 2600510

Filing Date : 2006-03-01

Strength per Unit : 20 mg

Dosage Form : TABLET

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2026-03-01

Date Granted : 2010-11-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Gowling WLG (Canada) LLP

Grapiprant

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-10-15

Date Granted : 2010-01-05

Brand Name : GALLIPRANT

Patent Number : 2426457

Filing Date : 2001-10-15

Strength per Unit : 20 mg

Dosage Form : TABLET

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2021-10-15

Date Granted : 2010-01-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Gowling WLG (Canada) LLP

Grapiprant

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-03-01

Date Granted : 2010-11-02

Brand Name : GALLIPRANT

Patent Number : 2600510

Filing Date : 2006-03-01

Strength per Unit : 60 mg

Dosage Form : TABLET

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2026-03-01

Date Granted : 2010-11-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Gowling WLG (Canada) LLP

Grapiprant

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-10-15

Date Granted : 2010-01-05

Brand Name : GALLIPRANT

Patent Number : 2426457

Filing Date : 2001-10-15

Strength per Unit : 60 mg

Dosage Form : TABLET

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2021-10-15

Date Granted : 2010-01-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Gowling WLG (Canada) LLP

Grapiprant

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-03-01

Date Granted : 2010-11-02

Brand Name : GALLIPRANT

Patent Number : 2600510

Filing Date : 2006-03-01

Strength per Unit : 100 mg

Dosage Form : TABLET

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2026-03-01

Date Granted : 2010-11-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Gowling WLG (Canada) LLP

Grapiprant

Peptide Process CMC

Not Confirmed

Gowling WLG (Canada) LLP

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-10-15

Date Granted : 2010-01-05

Brand Name : GALLIPRANT

Patent Number : 2426457

Filing Date : 2001-10-15

Strength per Unit : 100 mg

Dosage Form : TABLET

Human Or VET : Veterinary

Route of Administration : ORAL

Patent Expiration Date : 2021-10-15

Date Granted : 2010-01-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!